APA (7th ed.) Citation

Wenzel, M., Theissen, L., Groener, D., Kriegmair, M., Graefen, M., Maurer, T., . . . Mandel, P. (2025). Cancer-control outcomes of Radium-223-pretreated lutetium- 177-PSMA radioligand vs. Radium- 223-naïve mCRPC patients. European journal of nuclear medicine and molecular imaging, 52(11), . https://doi.org/10.1007/s00259-025-07256-5

Chicago Style (17th ed.) Citation

Wenzel, Mike, et al. "Cancer-control Outcomes of Radium-223-pretreated Lutetium- 177-PSMA Radioligand Vs. Radium- 223-naïve MCRPC Patients." European Journal of Nuclear Medicine and Molecular Imaging 52, no. 11 (2025). https://doi.org/10.1007/s00259-025-07256-5.

MLA (9th ed.) Citation

Wenzel, Mike, et al. "Cancer-control Outcomes of Radium-223-pretreated Lutetium- 177-PSMA Radioligand Vs. Radium- 223-naïve MCRPC Patients." European Journal of Nuclear Medicine and Molecular Imaging, vol. 52, no. 11, 2025, https://doi.org/10.1007/s00259-025-07256-5.